The proteins selected for validation were therefore—COMP, EFEMP1, FBLN1, GSN and PROS (changed in bvFTD) and CKM, COMP, and GSN (changed in ALS). The gene discussed is PROS1; the disease is amyotrophic lateral sclerosis.